Diwa, Aizarah .

HRN: 22-61-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2026
CEFUROXIME 1.5GM (VIAL)
01/10/2026
01/11/2026
IV
1.5g
Q8
S/p CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines